KMID : 0811720090130030153
|
|
Korean Journal of Physiology & Pharmacology 2009 Volume.13 No. 3 p.153 ~ p.159
|
|
Deficiency of iNOS Does Not Prevent Isoproterenol-induced Cardiac Hypertrophy in Mice
|
|
Cha Hye-Na
Hong Geu-Ru Kim Yong-Woon Kim Jong-Yeon Dan Jin-Myoung Park So-Young
|
|
Abstract
|
|
|
We investigated whether deficiency of inducible nitric oxide synthase (iNOS) could prevent isoproterenol-induced cardiac hypertrophy in iNOS knockout (KO) mice. Isoproterenol was continuously infused subcutaneously (15 mg/kg/day) using an osmotic minipump. Isoproterenol reduced body weight and fat mass in both iNOS KO and wild-type mice compared with saline-infused wild-type mice. Isoproterenol increased the heart weight in both iNOS KO and wild-type mice but there was no difference between iNOS KO and wild-type mice. Posterior wall thickness of left ventricle showed the same tendency with heart weight. Protein level of iNOS in the left ventricle was increased in isoproterenol-infused wild-type mice. The gene expression of interleukin-6 (IL-6) and transforming growth factor-? (TGF-?) in isoproterenol-infused wild-type was measured at 2, 4, 24, and 48-hour and isoproterenol increased both IL-6 (2, 4, 24, and 48-hour) and TGF-? (4 and 24-hour). Isoproterenol infusion for 7 days increased the mRNA level of IL-6 and TGF-? in iNOS KO mice, whereas the gene expression in wild-type mice was not increased. Phosphorylated form of extracellular signal-regulated kinases (pERK) was also increased by isoproterenol at 2 and 4-hour but was not increased at 7 days after infusion in wild-type mice. However, the increased pERK level in iNOS KO mice was maintained even at 7 days after isoproterenol infusion. These results suggest that deficiency of iNOS does not prevent isoproterenol- induced cardiac hypertrophy and may have potentially harmful effects on cardiac hypertrophy.
|
|
KEYWORD
|
|
Inducible nitric oxide synthase, Isoproterenol, Cardiac hypertrophy
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|